Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 337-342

  Loktionov, Alexandre ^a   O'Neill, Ian K ^a,b   Silvester, Katharine R ^a   Cummings, John H ^a   Middleton, Steve J ^a   Miller, Richard ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b Microprevention Tests Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; FECES; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECTUM POLYP; SCREENING TEST;

ADULT; AGED; AGED, 80 AND OVER; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; MIDDLE AGED;

EID: 0031889262     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics. CA Cancer J. Clin., 44: 7-26, 1994.
2. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardello, F. N., Sisk, J. E., van Antwerp, R., Brown-Davis, C., Marciniak, D. A., and Mayer, R. J. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112: 594-642, 1997.
3. Greegor, D. H. Diagnosis of large-bowel cancer in the asymptomatic patient. J. Am. Med. Assoc., 201: 943-945, 1967.
4. Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, M., Schuman, L. M., and Ederer, F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med., 328: 1365-1371, 1993.
5. Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H. E., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., and Maugham, C. M. Randomised controlled trial of fecal-occult blood screening for colorectal cancer. Lancet, 348: 1472-1477, 1996.
6. Fleisher, M., Winawer, S. J., Zauber, A. G., Smith, C., and Schwartz, M. M. K. Accuracy of fecal occult blood test interpretation. Ann. Intern. Med., 114: 875-876, 1991.
7. Alison, J. E., Tekawa, I. S., Ransom, L. J., and Adrain, A. L. A comparison of fecal occult-blood tests for colorectal cancer screening. N. Engl. J. Med., 334: 155-159, 1996.
8. Bader, G. M., and Papanicolau, G. N. The application of cytology in the diagnosis of cancer of the rectum, sigmoid, and descending colon. Cancer (Phila.), 5: 307-314, 1952.
9. Raskin, H. F., Palmer, W. L., and Kirshner, J. B. Exfoliative cytology in diagnosis of cancer of the colon. Dis. Colon Rectum, 2: 46-57, 1959.
10. Iyengar, V., Albaugh, G. P., Lohani, A., and Nair, P. P. Human stools as a source of viable colonie epithelial cells. FASEB J., 5: 2856-2859, 1991.
11. Albaugh, G. P., Iyengar, V., Lohani, A., Malayeri, M., Bala, S., and Nair, P. P. Isolation of exfoliated colonic epithelial cells, a novel non-invasive approach to the study of cellular markers. Int. J. Cancer, 52: 347-350, 1992.
12. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
13. Bodmer, W. The somatic evolution of cancer. J. R. Coll. Phys. Lond., 31: 82-89, 1997.
14. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras-oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 256: 3102-3105, 1992.
15. Smith-Ravin, J., England, J., Talbot, I. C. and Bodmer, W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut, 36: 81-86, 1995.
16. Nollau, P., Moser, C., Weinland, G., Wagener, C. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int. J. Cancer, 66: 332-336, 1996.
17. Villa, E., Dugani, A., Rebacchi, A. M., Vignoli, A., Grottola, A., Buttafoco, P., Losi, L., Perini, M., Trande, P., Merighi, A., Lerose, R., and Manenti, F. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology, 110: 1346-1353, 1996.
18. Loktionov, A., and O'Neill, I. K. Early detection of cancer-associated gene alterations in DNA isolated from rat feces during intestinal tumor induction with 1,2-dimethylhydrazine. Int. J. Oncol., 6: 437-445, 1995.
19. O'Neill, I. K., and Loktionov, A. Method of isolating cells. UK patent application 1995; 9518156.6 and PCT/GB96/02177; International Publication Number WO 97/09600, 1997.
20. Hart, C. Theory and its applications. In: C. R. Hart and P. Burke (eds.), Screening and Surveillance in General Practice, pp. 15-23. Edinburgh: Churchill Livingstone, 1992.
21. Dutta, S. K., Silverstein, R. J., Fleisher, A. S., Vengurlekar, S. M., Shami, S., and Nair, P. P. Increased expression of CD44 in isolated fecal colonocytes in patients with colonie neoplasia. Gastroenterology, 108 (Suppl.): A463, 1995.
22. Matsuo, K., Ota, H., Akamatsa, T., Sugiyama, A., and Katsuyama, T. Histochemistry of the surface mucus gel layer of the human colon. Gut, 40: 782-789, 1997.
23. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Gioccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
24. Terpstra, O. T., van Blankenstein, M., Dees, J., Eilers, G. A. M. Abnormal pattern of cell proliferation in the entire colonie mucosa of patients with colon adenoma or cancer. Gastroenterology, 92: 704-708, 1987.
25. Rosen, P., Fireman, Z., Fine, N., Wax, Y., and Ron, E. Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. Gut, 30: 650-655, 1989.
26. Risio, M., Lipkin, M., Candelaresi, G-L., Bertone, A., Coverlizza, S., and Rossini, F. P. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res., 51: 1917-1921, 1991.
27. Garewal, H., Bernstein, H., Bernstein, C., Sampliner, R., and Payne, C. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Res., 56: 1480-1483, 1993.
28. Wang, J., Whetsell, M., and Klein, J. R. Local hormone networks and intestinal T cell homeostasis. Science (Washington DC), 275: 1937-1939, 1997.
29. Shanahan, F. A gut reaction: lymphoepithelial communication in the intestine. Science (Washington DC), 275: 1897-1898, 1997.
30. 2-terminal deletion of β-catenin results in stable colocalization of mutant β-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell Biol., 136: 693-706, 1997.
31. Weaver, V. M., and Roskelley, C. D. Extracellular matrix: the central regulator of cell and tissue homeostasis. Trends Cell Biol., 7: 40-42, 1997.
32. Slaughter, D. P., Southwick, H. W., and Smejkal, W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
33. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
34. Boland, R. C., Sato, J., Appelman, H. D., Bresalier, R. S., and Feinberg, A. P. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat. Med., 1: 902-909, 1995.
35. Califano, J., Arendt, S. A., Meininger, G., Westra, W. H., Koch, W. M., and Sidransky, D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res., 56: 5720-5722, 1996.
36. Yoshida, K., Sugino, T., Goodison, S., Warren, B. F., Nolau, D., Wadsworth, S., and Mortensen, N. J. Detection of telomerase activity in exfoliated cells in colonic luminal washings and its related clinical implications. Br. J. Cancer, 75: 548-553, 1997.
37. Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Mitsumori, K., Itoh, N., Yamada, H., Terachi, T., and Yoshida, O. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. Natl. Cancer Inst., 89: 724-730, 1997.